Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LIG1 | P18858 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11880209 | 0.78 | — | — | |
| SCHEMBL6022461 | 0.78 | — | — | |
| SCHEMBL11880200 | 0.78 | — | — | |
| SCHEMBL502220 | 0.73 | MAPT (0.38) | — | |
| SCHEMBL6464295 | 0.73 | AKT1 (0.34) | — | |
| SCHEMBL1286136 | 0.73 | KDM4E (0.33) | BLMSMN1; SMN2 | |
| SCHEMBL8909319 | 0.73 | — | — | |
| SCHEMBL22144483 | 0.71 | SIRT1 (0.47) | SMN1; SMN2 | |
| SCHEMBL9952462 | 0.69 | TSHR (0.32) | — | |
| SCHEMBL2027730 | 0.69 | ALDH1A1 (0.43) | ALOX15SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109824897-A | A kind of polyamidoimide and preparation method thereof | 株洲时代新材料科技股份有限公司 | 2019-05-31 | — | — | CN | claimed |
| CN-108892631-A | A kind of heat stabilizer and its synthetic method for PVC | 广州臻莱迈新材料科技有限公司 | 2018-11-27 | — | — | CN | claimed |
| EP-1597271-B1 | PEPTIDES DIRECTED AGAINST ANTIBODIES, WHICH CAUSE COLD-INTOLERANCE, AND THE USE THEREOF | MAX DELBRUECK CENTRUM (DE) | 2013-03-06 | — | — | EP | claimed |
| CN-101611320-A | Method for detecting antibodies in body fluids by immunoreaction of glycoprotein 2(GP2) from zymogen granules of pancreas for diagnosing inflammatory bowel disease and chronic pancreatitis | GA GENERIC ASSAYS GMBH (DE) | 2009-12-23 | — | — | CN | claimed |
| CN-100360554-C | peptide conjugates | UNIV KEIO (JP) | 2008-01-09 | — | — | CN | claimed |
| CN-1303130-C | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2007-03-07 | — | — | CN | claimed |
| CN-1747967-A | Peptide conjugate | UNIV KEIO (JP) | 2006-03-15 | — | — | CN | claimed |
| CN-1714113-A | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2005-12-28 | — | — | CN | claimed |
| US-20040023048-A1 | Enhanced bonding layers on native oxide surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-02-05 | — | — | US | claimed |
| US-5232560-A | Polymerizing at least one carboxy group containing monomer from aqueous solution onto electrically conductive filler material; thermally stable thermoplastic coatings; prepregs | BELL JAMES P (US) | 1993-08-03 | — | — | US | claimed |
| US-4131707-A | POLYMALEIMIDES | CIBA-GEIGY CORPORATION (US) | 1978-12-26 | — | — | US | claimed |
| JP-4023980-A | — | — | None | — | — | JP | disclosed |
| US-20240165934-A1 | CURABLE RESIN MULTILAYER BODY, DRY FILM, CURED PRODUCT AND ELECTRONIC COMPONENT | TAIYO HOLDINGS CO., LTD. (JP) | 2024-05-23 | — | — | US | disclosed |
| US-11905356-B2 | Bismaleimide compound, composition containing same, polybenzoxazole, and semiconductor device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2024-02-20 | — | — | US | disclosed |
| CN-116867646-A | Curable resin laminate, dry film, cured product, and electronic component | 太阳控股株式会社 | 2023-10-10 | — | — | CN | disclosed |
| EP-0363211-A1 | 1Alpha or 24R,25-Dihydroxy vitamin D3 derivatives, process for their production and assay method using the same | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1990-04-11 | — | — | EP | disclosed |
| EP-0312360-A2 | 25-Hydroxy vitamin D3 derivatives | TOYO JOZO KABUSHIKI KAISHA (JP) | 1989-04-19 | — | — | EP | disclosed |
| EP-0228810-A1 | Enzyme immunoassay method for epidermal growth factor | NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD (JP) | 1987-07-15 | — | — | EP | disclosed |
| US-4495151-A | Element for immunoassay | TOYO JOZO KABUSHIKI KAISHA (JP) | 1985-01-22 | — | — | US | disclosed |
| US-4131707-A | POLYMALEIMIDES | CIBA-GEIGY CORPORATION (US) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11905356-B2 | Bismaleimide compound, composition containing same, polybenzoxazole, and semiconductor device | GABRE, SMCHD1, BRIX1 | LDHA 984/4885ALOX15 2731/4885NFKB1 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.